Skip to main content
. 2016 Aug 3;20(2):294–304. doi: 10.1017/S1368980016002019

Table 1.

Distribution of number and type of supplements consumed across five time points in a population-based prospective cohort of women with a viable singleton pregnancy (n 2146), Melbourne, Australia, July 2011–July 2012

3MP (n 2146) PPA (n 2146) T1 (n 2146) T2 (n 1715) T3 (n 1571)
% n % n % n % n % n
Taking a supplement 64 1379 64 1382 91 1952 88 1505 91 1434
Nil 36 767 36 764 9 194 12 210 9 136
One 37 787 37 791 45 962 33 567 32 497
Two 18 385 20 428 32 695 35 608 34 539
Three or more 10 207 8 163 14 295 19 330 25 398
Supplement types* SU TS n SU TS n SU TS n SU TS n SU TS n
General multivitamin 35 22 477 34 22 466 34 31 657 31 27 461 39 35 557
Pregnancy/conception multivitamin 39 25 533 40 26 556 52 47 1014 58 51 873 50 46 717
B vitamin multivitamin 1·5 1 22 1 1 19 1 1 17 <1 1 10 <1 <1 7
Folate and Iodine 2·5 2 36 3 2 39 2 2 39 1·5 1 23 1 1 14
Folate 24 15 329 21 14 291 17 15 326 8 7 124 5 4 68
Zinc 1 1 18 1 1 15 <1 <1 9 <1 1 10 <1 1 9
Iron 5 3 72 5 3 71 5 4 92 7 6 105 14 13 206
Vitamin B12 <1 <1 5 <1 <1 7 <1 <1 8 <1 <1 7 1 1 14
Vitamin D 18·5 12 254 21 14 295 35 32 688 52 45 777 53 48 761
Fish/cod liver oils 13 9 186 12 8 171 7 6 135 8 7 119 7 7 107
Calcium 1 1 11 1 1 13 1·5 1 28 2 1 25 2 2 26
Vitamin D and calcium 1 1 18 1 1 18 2 2 33 3 3 45 4 3 54
Herbal 5 3 65 3 2 44 1·5 1 28 1·5 1 22 4 3 53
Other 8 5 108 7 5 102 6 5 118 8 7 122 8 7 117
Any folic acid preparation 62 40 853 62 40 858 68 62 1320 66 58 991 54 50 780

3MP, three months prior to conception; PPA, after conception but prior to pregnancy awareness; T1, from awareness to gestational week 13; T2, second trimester; T3, third trimester; SU, proportion of supplement users (%), TS, proportion of total sample (%).

*

Categories are not mutually exclusive, as some women are consuming two or more supplement types.

Includes single or combined use of a pregnancy multivitamin, folic acid-specific supplement and folic acid/iodine supplement.